First-generation antihistamines increase delirium risk in older hospitalized patients

An analysis in the Journal of the American Geriatrics Society reveals that older inpatients admitted to physicians who prescribe higher amounts of first-generation antihistamines face an elevated risk of delirium while in the hospital.

First-generation antihistamines, such as diphenhydramine (Benadryl), are among the leading causes of medication-related harms in older adults, and although these medications are indicated for histamine-related conditions such as hives and anaphylaxis, they may be prescribed inappropriately.

When investigators analyzed data on 328,140 patients aged 65 years and older who were admitted by 755 attending physicians to 17 hospitals in Ontario, Canada in 2015–2022, they found that the overall prevalence of delirium was 34.8%. Patients admitted to physicians who more commonly prescribed first-generation antihistamines had 41% increased odds of experiencing delirium compared with patients admitted to physicians who rarely prescribed first-generation antihistamines.

We hope our study raises awareness among hospitalists that sedating antihistamines can be harmful, and should be prescribed with caution."

Aaron M. Drucker, MD, corresponding author, University of Toronto and Women's College Hospital

Source:
Journal reference:

Bridgman, A. C., et al. (2025) Association of inpatient prescribing of first-generation antihistamines with delirium in older adults. Journal of the American Geriatrics Societydoi.org/10.1111/jgs.70121

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New update to the 2023 AGS Beers Criteria highlights safer pharmacologic options for older adults